EMAIL THIS PAGE TO A FRIEND

Journal of Nuclear Medicine

Somatostatin receptor-targeted radiopeptide therapy with 90Y-DOTATOC and 177Lu-DOTATOC in progressive meningioma: long-term results of a phase II clinical trial.


PMID 25593116

Abstract

We're sorry this abstract is currently not available.